Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Haupt Pharma Passes FDA Inspection | Contract Pharma

What are you searching for?

Sign in
Breaking News

Haupt Pharma Passes FDA Inspection

Haupt Pharma has successfully passed an inspection by the FDA at its Amareg site in Regensburg, Germany without any FDA-483 observation issued.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Haupt Pharma has successfully passed an inspection by the FDA at its Amareg site in Regensburg, Germany without any FDA-483 observation issued. Haupt Pharma Amareg provides contract manufacturing, packaging and quality control in many dosage forms. The company specializes in solid dosage forms with highly active substances.

“The management board congratulates Haupt Pharma Amareg on its successful completion of the FDA inspection. This is a fundamental element in the continuing efforts to further increase the value and appeal of this site,” said Dr Karl Heinz Brücher, chief operating officer of Haupt Pharma.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters